ROC curves revealed that area under the curves of GSE16515 (Fig. 1D) and GSE183795 (Fig. 1E) were 0.826 [95% confidence interval (CI) 0.698–0.929] and 0.857 (95% CI 0.807–0.9), indicating that MICAL2 shows potential as a diagnostic biomarker for pancreatic cancer. Here, MICAL2 is linked to pancreatic neoplasm.